News
News
- TILT Holdings Inc. Statement on CDA Lawsuit
00:19 - GlobeNewswire - First US Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product
01/24/2021 / 23:54 - GlobeNewswire - Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia
01/20/2021 / 12:30 - GlobeNewswire - PTA-News: coinIX GmbH & Co. KGaA: Blockchain-Investor coinIX increases its investment in Publc - The Search engine for the Web3.0
01/15/2021 / 09:45 - pressetext - Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC
01/14/2021 / 11:00 - GlobeNewswire - Philips and Merck partner to advance personalized fertility treatment
01/14/2021 / 10:00 - GlobeNewswire - Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
01/14/2021 / 08:00 - GlobeNewswire - Velano Vascular Named Top Impact Company for 2021 by Real Leaders
01/13/2021 / 15:00 - GlobeNewswire - ESPERION Reports Preliminary Fourth Quarter 2020 Financial Results and Further Commits to Unmet Patient Needs with Oral PCSK9 Inhibitor Program
01/13/2021 / 12:26 - GlobeNewswire - Helsinn Announces First Patient Dosed in Phase 1/2 Study of TAS0953/HM06 in Patients with Advanced Solid Tumors with RET Gene Abnormalities
01/12/2021 / 09:30 - GlobeNewswire
Real-time